In line with this finding, a higher VRK2 expression level correlated with a shorter overall survival (OS) time in 121 HCC patients (Fig. 7d; hazard ratio = 0.3634, p < 0.001) and was identified as an independent risk factor in HCC patients (Supplementary Table 4). Here, VRK2 is linked to hepatocellular carcinoma.